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Abstract: Aquaporin-11 (AQP11) is expressed in human adipocytes, but its functional role remains 
unknown. Since AQP11 is an endoplasmic reticulum (ER)-resident protein that transports water, 
glycerol, and hydrogen peroxide (H2O2), we hypothesized that this superaquaporin is involved in 
ER stress induced by lipotoxicity and inflammation in human obesity. AQP11 expression was 
assessed in 67 paired visceral and subcutaneous adipose tissue samples obtained from patients with 
morbid obesity and normal-weight individuals. We found that obesity and obesity-associated type 
2 diabetes increased (p < 0.05) AQP11 mRNA and protein in visceral adipose tissue, but not 
subcutaneous fat. Accordingly, AQP11 mRNA was upregulated (p < 0.05) during adipocyte 
differentiation and lipolysis, two biological processes altered in the obese state. Subcellular 
fractionation and confocal microscopy studies confirmed its presence in the ER plasma membrane 
of visceral adipocytes. Proinflammatory factors TNF-α, and particularly TGF-β1, downregulated (p 
< 0.05) AQP11 mRNA and protein expression and reinforced its subcellular distribution 
surrounding lipid droplets. Importantly, the AQP11 gene knockdown increased (p < 0.05) basal and 
TGF-β1-induced expression of the ER markers ATF4 and CHOP. Together, the downregulation of 
AQP11 aggravates TGF-β1-induced ER stress in visceral adipocytes. Owing to its “peroxiporin” 
properties, AQP11 overexpression in visceral fat might constitute a compensatory mechanism to 
alleviate ER stress in obesity.  
Keywords: aquaporins; obesity; endoplasmic reticulum stress 
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1. Introduction 
Aquaporins (AQPs) are membrane channels that facilitate the movement of water across 
biological membranes [1]. AQP structure is composed of six transmembrane α-helices and two 
reentrant loops with two asparagine–proline–alanine (NPA) signature motifs, which create the 
aperture of a water channel pore-forming a tridimensional “hourglass” structure in the lipid bilayer 
[2]. Based on their permeability, AQPs are classically subdivided into “orthodox aquaporins” (AQP0, 
AQP1, AQP2, AQP4, AQP5, AQP6, and AQP8), which are mainly pure water channels [3,4], and 
“aquaglyceroporins” (AQP3, AQP7, AQP9, and AQP10), which are permeated by water and other 
small solutes, such as glycerol, urea or nitric oxide [5]. A third subfamily of AQPs, unorthodox or 
“superaquaporins” (AQP11 and AQP12), exhibit unique Asn-Pro-Cys (NPC) motifs in AQP11 and 
Asn-Pro-Thr (NPT) in AQP12, and are located in the membranes of intracellular organelles [6–8]. This 
archetypical classification based on the transporting properties has been recently blurred because 
AQP11 is permeated by water [8], glycerol [9], and hydrogen peroxide (H2O2) [10]. Moreover, this 
ability to transport H2O2 is also observed in several orthodox AQPs (AQP5 and AQP8) [11,12] and 
aquaglyceroporins (AQP3 and AQP9) [13,14] that, together with superaquaporin AQP11 [10], are 
collectively termed “peroxiporins”. H2O2 acts as a signaling molecule in various cellular processes, 
including endoplasmic reticulum (ER) redox homeostasis and signaling, and therefore, these AQPs 
with peroxiporin activity are a matter of intense investigation in all human organs and tissues [10].  
AQP11 (originally named AQPX1) is highly expressed in testis and, to a lesser extent, in the 
kidney, liver, brain, and adipose tissue [9,15]. AQP11 functions as an ER-resident peroxiporin, and 
its downregulation perturbs the flux of H2O2 through the ER, but not through the mitochondrial or 
plasma membranes [10]. In line with this observation, transgenic Aqp11-knockout mice die before 
weaning with progressive vacuolization and cyst formation of the proximal tubule, leading to lethal 
polycystic kidney disease with marked signs of oxidative stress [16–18]. These ER stress-related 
vacuoles are also observed in hepatocytes of liver-specific Aqp11-knockout mice [19]. Thus, AQP11 
constitutes an important regulator of renal and hepatic ER redox homeostasis and signaling.  
Obesity is a condition of low-grade chronic inflammation. Failure of the unfolded protein 
response (UPR), an ER stress response to restore protein homeostasis, is one of the signals that 
perpetuate the chronic inflammation in adipose tissue and liver in obesity [20–22], but little is known 
about the mechanisms triggering obesity-induced ER stress. The ER-resident AQP11 was identified 
close to lipid droplets in human adipocytes [8], but its function remains undefined. Therefore, our 
hypothesis was that AQP11 is involved in the relationship between ER stress and chronic 
inflammation in the context of human obesity and obesity-associated type 2 diabetes (T2D). To gain 
insight into the regulation of AQP11, the role of tumor necrosis factor α (TNF-α) and transforming 
growth factor β1 (TGF-β1), two molecules tightly involved in obesity-associated inflammation and 
ER stress, was analyzed as plausible regulators of AQP11 in human omental adipocytes. 
2. Materials and Methods 
2.1. Patient Selection 
Paired omental and subcutaneous adipose tissue samples (n = 67) were collected from patients 
undergoing either laparoscopic Roux-en-Y gastric bypass for morbid obesity treatment (n = 53, 
patients with obesity) or laparoscopic hiatal hernia repair with Nissen fundoplication (n = 14; control 
lean patients) at the Clínica Universidad de Navarra. Body mass index (BMI) was calculated as 
weight in kilograms divided by the square of height in meters, and body fat (BF) was estimated by 
air-displacement plethysmography (Bod-Pod®; Life Measurements, Concord, CA, USA). Obesity was 
classified according to both BMI (≥30 kg/m2) and %BF (BF ≥25% in males and ≥35% in females). Obese 
patients were sub-classified into two groups (normoglycemia (NG) or impaired glucose tolerance 
(IGT)/T2D) following the criteria of the Expert Committee on the Diagnosis and Classification of 
Diabetes [23]. It has to be stressed that the patients included in the T2D group did not have a long 
diabetes history (less than 2–3 years or even de novo diagnosis, as evidenced by their anamnesis and 
biochemical determinations). Biochemical and hormonal assays performed in the study subjects were 
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measured as previously described [24]. All reported investigations were carried out in accordance 
with the principles of the Declaration of Helsinki, as revised in 2013, by the Hospital’s Ethical 
Committee (protocol 2017.104, approved in June 2017). Informed consent from all volunteers was 
obtained. 
2.2. Adipose Tissue Handling 
Paired samples of omental and subcutaneous fat samples were collected during elective surgical 
procedures and immediately stored at −80 °C for gene and protein expression analyses. A portion of 
omental and subcutaneous adipose tissue was fixed in 4% formaldehyde for histological analyses. 
Another portion of omental fat was used for the isolation of adipocytes and stromal vascular fraction 
cells (SVFC) by 2% collagenase digestion, as previously described [24]. Total RNA isolation and 
purification was performed using QIAzol® Reagent (Qiagen, Hilden, Germany) and RNeasy Lipid 
Tissue Mini Kit (Qiagen) for adipose tissue and adipocytes, and TRIzol® Reagent (Invitrogen, Paisley, 
UK) and RNeasy Mini Kit (Qiagen) for SVFC, according to the manufacturer’s instructions. Finally, 
200 mg of omental and subcutaneous adipose tissue was homogenized in ice-cold lysis buffer (0.1% 
SDS, 1% Triton X-100, 5 mmol/L EDTA·2H2O, 1 mol/L Tris-HCl, 150 mmol/L NaCl, 1% sodium 
deoxycholate, pH 7.40) supplemented with a protease inhibitor cocktail (CompleteTM Mini-EDTA 
free, Roche, Mannheim, Germany). Lysates were centrifuged at 16,000× g at 4 °C for 15 min to remove 
nuclei and unruptured cells. Total protein concentrations were determined by the Bradford assay, 
using bovine serum albumin (BSA) (Sigma, St Louis, MO, USA) as standard. 
2.3. Adipocyte Cultures 
Human omental SVFC were seeded at 2 x 105 cell/cm2 and grown in adipocyte medium 
(DMEM/F-12 (1:1); Invitrogen), 17.5 mmol/L glucose, 16 µmol/L biotin, 18 µmol/L panthotenate, 100 
µmol/L ascorbate and antibiotic-antimycotic] supplemented with 10% newborn calf serum (NCS). 
After 4 days, the medium was changed to adipocyte medium supplemented with 3% NCS, 0.5 
mmol/L 3-isobutyl-1-methylxanthine (IBMX), 0.1 µmol/L dexamethasone, 1 µmol/L BRL49653 and 10 
µg/mL insulin. After a 3-day induction period, cells were fed every 2 days with the same medium 
but without IBMX and BRL49653 supplementation for the remaining 7 days of adipocyte 
differentiation. Differentiated adipocytes were serum-starved for 24 h and then treated with TNF-α 
(1, 10, and 100 ng/mL) (PeproTech EC, Inc., Rocky Hill, NJ, USA), TGF-β1 (0.1, 1, and 10 ng/mL) 
(Peprotech), insulin (1, 10, and 100 nmol/L) (Sigma) and isoproterenol (10 µmol/L) (Sigma) for 24 h. 
One sample per experiment was used to obtain control responses in the presence of the solvent. 
2.4. Subcellular Fractionation Studies 
Lipid droplets (LDs), cytosolic, and crude membrane fractions were isolated by centrifugation 
of protein extracts from differentiated adipocytes in sucrose density gradients according to our 
previously validated protocols [25,26]. Briefly, cells were rinsed with Ca2+- and Mg2+-free PBS 
(Invitrogen) and resuspended in 3 mL lysis buffer containing 25 mmol/L Tris-HCl, 100 mmol/L KCl, 
1 mmol/L EDTA, 5 mmol/L EGTA, and 1 µg/mL anti-protease cocktail (pH 7.40). Cells were disrupted 
and mixed with an equal volume of lysis buffer containing 1.08 mol/L sucrose, and extracts were 
centrifuged at 1500× g for 10 min. Supernatants were transferred to a 12 mL ultracentrifuge tube and 
sequentially overlaid with 2 mL each of 0.27 mol/L and 0.135 mol/L sucrose buffer and, finally, free-
sucrose solution containing 25 mmol/L Tris-HCl, 1 mmol/L EDTA, and 1 mmol/L EGTA (pH 7.40). 
After centrifugation at 130,000× g at 4 °C for 1 h, protein distribution was analyzed by Western-blot 
using 50 µg from the fractions containing LDs (fractions 1–2), cytosol (5–7) and membranes (8–9). 
2.5. AQP11 Knockdown by siRNA Transfection 
MISSION® esiRNA targeting human AQP11 mRNA (EHU037771) and MISSION® siRNA 
Universal negative control number 1 (SIC001) were purchased from Sigma–Aldrich. MISSION® 
esiRNA are a heterogeneous mixture of siRNAs that all target the same mRNA sequence, which 
Cells 2020, 9, 1403 4 of 14 
 
conducts highly specific and effective gene silencing. Control and AQP11 siRNAs (100 pmol/L, final 
concentration) were complexed with 5 µL of Lipofectamine® 2000 reagent (Invitrogen) in serum-free 
Opti-MEM® I (Invitrogen). After 20 min incubation at room temperature (RT), the mix was added to 
cells and incubated at 37 °C for 4 h. The transfection mixes were then completely removed and fresh 
adipocyte culture media were added. Knockdown effectiveness after 24 h was determined by real-
time PCR.  
2.6. Real-Time PCR 
Transcript levels for AQP11 (AQP11), activating transcription factor 4 (ATF4), and DNA 
damage-inducible transcript 3 (DDIT3) were quantified by real-time PCR (7300 Real-Time PCR 
System; Applied Biosystems, Foster City, CA, USA). Primers and probes (Supplementary Table S1) 
were designed using the software Primer Express 2.0 (Applied Biosystems) and purchased from 
Genosys (Sigma). Primers or TaqMan® probes encompassing fragments of the areas from the 
extremes of two exons were designed to ensure the detection of the corresponding transcript avoiding 
genomic DNA amplification. The cDNA was amplified at the following conditions: 95 °C for 10 min, 
followed by 45 cycles of 15 s at 95 °C and 1 min at 59 °C, using the TaqMan® Universal PCR Master 
Mix (Applied Biosystems). The primer and probe concentrations were 300 and 200 nmol/L, 
respectively. All results were normalized for the expression of 18S rRNA (Applied Biosystems), and 
relative quantification was calculated using the 2−∆∆Ct formula [27]. Relative mRNA expression was 
expressed as fold expression over the calibrator sample. All samples were run in triplicate and the 
average values were calculated. 
2.7. Western-Blot 
Samples (30 g) were run out in 10% SDS-PAGE, transferred to nitrocellulose membranes (Bio-
Rad Laboratories, Inc., Hercules, CA, USA) and blocked in Tris-buffered saline (10 mmol/L Tris-HCl, 
150 mmol/L NaCl, pH 8.00) with 0.05% Tween 20 (TBS-T) containing 5% non-fat dry milk for 1 h at 
RT. Blots were then incubated overnight at 4 °C with rabbit polyclonal anti-human AQP11 
(HPA042879, Sigma) or murine monoclonal anti-β-actin (Sigma) antibodies (diluted 1:1000 and 
1:5000, respectively, in blocking solution). The antigen-antibody complexes were visualized using 
horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibodies (diluted 1:5000 in 
blocking solution) and the enhanced chemiluminescence ECL Plus detection system (Amersham 
Biosciences, Buckinghamshire, UK). The band intensities were determined by densitometric analysis 
with the Gel DocTM system and Quantity One 4.5.0 software (Bio-Rad) and normalized with β-actin 
density values.  
2.8. Immunohistochemistry of AQP11 
The indirect immunoperoxidase method was used to detect AQP11 in histological sections of 
omental and subcutaneous fat [24]. Sections of formalin-fixed paraffin-embedded adipose tissue (6 
µm) were dewaxed in xylene, rehydrated in decreasing concentrations of ethanol and treated with 
3% H2O2 (Sigma) in absolute methanol for 10 min at RT to quench endogenous peroxidase activity. 
Slides were blocked during 30 min with 1% murine serum (Sigma) diluted in Tris-buffer saline (TBS) 
(50 mmol/L Tris, 0.5 mol/L NaCl; pH 7.36) to prevent nonspecific adsorption. Sections were incubated 
overnight at 4 °C with rabbit polyclonal anti-human AQP11 (HPA042879, Sigma) antibody diluted 
1:1000 in TBS. After washing three times (5 min each) with TBS, slides were incubated with DAKO 
RealTM EnVisionTM anti-rabbit/mouse (K5007; Dako, Golstrup, Denmark) for 1 h at RT. The peroxidase 
reaction was visualized using a 0.5 mg/mL diaminobenzidine (DAB)/0.03% H2O2 solution diluted in 
50 mmol/L Tris-HCl, pH 7.36, and Harris hematoxylin solution (Sigma) as counterstaining. Negative 
control slides without primary antibody were included to assess nonspecific staining. 
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2.9. Confocal Immunofluorescence Microscopy of AQP11 
Differentiated adipocytes grown on glass coverslips were fixed with 4% formaldehyde for 15 
min at RT, incubated with PBS containing 0.3% saponin and 1% BSA for 1 h at RT, and exposed to 
rabbit polyclonal anti-human AQP11 antibody (HPA042879, Sigma) diluted 1:100 in PBS containing 
0.3% saponin and 0.5% BSA overnight at 4 °C. Thereafter, cells were washed with PBS and incubated 
with Alexa Fluor® 488-conjugated donkey anti-rabbit IgG (Invitrogen) diluted 1:500 for 2 h at RT. 
After washing, coverslips were mounted on microscope slides and examined under a TCS-SP2-AOBS 
confocal laser scanning microscope (Leica Corp., Heidelberg, Germany). After acquisition, images 
underwent a deconvolution process with the Huygens Essential 2.4.4 software (Scientific Volume 
Imaging, Hilversum, The Netherlands). 
2.10. Statistical Analysis 
Statistical analyses were performed using the SPSS 15.0 software. Data are expressed as the mean 
± SEM. Statistical differences between mean values were analyzed using Student’s t-test, χ2 test, one-
way ANOVA followed by Scheffe’s or Dunnett’s post hoc tests, or two-way ANOVA, where 
appropriate. Pearson correlation coefficients (r) were used to analyze the association between 
variables. A p-value <0.05 was considered statistically significant.  
3. Results 
3.1. Obesity and Obesity-Associated Type 2 Diabetes Upregulated AQP11 Expression in Human Visceral 
Fat 
The clinical characteristics of our cohort are summarized in Table 1. Fifteen patients (22.4%) were 
on antihypertensive treatment, four subjects (5.9%) were on oral antidiabetic drugs, and six 
individuals (9.0%) were on lipid-lowering medications. No differences in age between groups were 
observed (p = 0.140). As expected, markers of adiposity (BMI, BF, or leptin) and lipolysis [circulating 
free fatty acids (FFA) and glycerol] were increased (p < 0.01) in both groups of patients with obesity 
compared to those of the lean individuals. Analogously, obese patients with T2D exhibited higher (p 
< 0.01) glycemia, insulinemia, HOMA, and Adipo-IR indices, as well as a lower QUICKI index (p < 
0.001). Obesity was also associated with an abnormal lipid profile, evidenced by increased reduced 
levels of HDL-cholesterol (p < 0.05). Moreover, patients with obesity exhibited increased circulating 
levels of markers of systemic inflammation, including C-reactive protein (CRP), fibrinogen, von 
Willebrand factor, or TNF-α (all p < 0.05), regardless of insulin resistance. 
Table 1. Clinical characteristics of the subjects of the study. 
 Lean Obese NG Obese IGT/T2D p 
n 14 24 29 - 
Sex (male/female) 6/8 10/14 13/16 0.973 
Age (years) 48 ± 3 41 ± 3 45 ± 2 0.140 
BMI (kg/m2) 23.1 ± 0.8 47.2 ± 1.5a 48.6 ± 1.6a <0.0001 
Body fat (%) 24.8 ± 2.8 51.7 ± 1.4a 52.1 ± 1.3a <0.0001 
Glucose (mg/dL) 85 ± 3 91 ± 2 120 ± 7a,b 0.001 
Glucose 2-h OGTT (mg/dL) - 119 ± 6 194± 14b <0.0001 
Insulin (µU/mL) 7.8 ± 1.4 21.1 ± 2.8a 23.9 ± 4.9a 0.004 
Insulin 2-h OGTT (µU/mL) - 93.2 ± 13.6 90.6 ± 7.3 0.862 
HOMA 1.7 ± 0.3 4.8 ± 0.7a 7.8 ± 2.0a 0.007 
QUICKI 0.36 ± 0.01 0.31 ± 0.01a 0.31 ± 0.01a 0.014 
FFA (mmol/L) 13.3 ± 1.6 17.0 ± 1.3 18.6 ± 1.9a 0.040 
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Glycerol (mg/dL) 22.5 ± 3.5 34.1 ± 3.4 44.4 ± 5.0a 0.008 
Adipo-IR index 21.1 ± 3.1 83.6 ± 11.6 108.6 ± 19.8a 0.003 
Triacylglycerol (mg/dL) 68 ± 9 135 ± 19a 165 ± 33a 0.011 
Total cholesterol (mg/dL) 191 ± 8 196 ± 8 200 ± 6 0.800 
LDL-cholesterol (mg/dL) 117 ± 8 119 ± 8 130 ± 6 0.448 
HDL-cholesterol (mg/dL) 59 ± 2 49 ± 5a 44 ± 2a 0.013 
CRP (mg/L) 2.3 ± 0.6 8.8 ± 1.4a 11.5 ± 2.8a 0.001 
Uric acid (mg/dL) 4.2 ± 0.4 9.2 ± 2.8a 6.5 ± 0.2a 0.007 
Leptin (ng/mL) 7.2 ± 1.4 46.9 ± 5.8a 53.5 ± 6.5a 0.004 
TNF-α (ng/mL) 0.87 ± 0.15 1.89 ± 0.12a 2.02 ± 0.41a 0.003 
Fibrinogen (mg/dL) 251 ± 42 358 ± 16a 372 ± 15a 0.003 
von Willebrand factor (%) 87 ± 11 126 ± 9a 154 ± 14a 0.025 
Antihypertensive therapy, n (%) 0 (0%) 7 (29%) 8 (28%) 0.092 
Antidiabetic therapy, n (%) 0 (0%) 0 (0%) 4 (14%) 0.041 
Lipid-lowering therapy, n (%) 0 (0%) 4 (17%) 2 (22%) 0.384 
NG, normoglycemia; IGT, impaired glucose tolerance; T2D, type 2 diabetes; BMI, body mass index; 
OGTT, oral glucose tolerance test; HOMA, homeostasis model assessment; QUICKI, quantitative 
insulin sensitivity check index; FFA, free fatty acids; Adipo-IR, adipocyte insulin resistance index; 
CRP, high-sensitivity C-reactive protein; TNF-α, tumor necrosis factor α. Differences between groups 
were analyzed by one-way ANOVA followed by a Scheffe´s test or Student’s t-test or χ2 test, where 
appropriate. Bold values denote statistically significant p values. ap < 0.05 vs normal-weight 
individuals; bp < 0.05 vs obese NG patients. 
First, we assessed the expression of AQP11 in paired omental and subcutaneous adipose tissue 
samples by real-time PCR, Western-blot, and immunohistochemistry. The tissue distribution of 
AQP11 in biopsies of omental and subcutaneous adipose tissue showed predominant brown 
immunostaining in fully mature adipocytes (Figure 1a). Accordingly, adipose tissue fraction analysis 
also revealed an increase (p <0.05) in AQP11 mRNA levels in adipocytes in comparison to SVFC, 
independently of the insulin resistance degree (Figure 1b). Lack of changes (p = 0.329) in AQP11 
mRNA expression after insulin treatment confirmed that this hormone is not a major regulator of 
AQP11 in human adipocytes (Figure S1). We next examined potential fat depot-differences in AQP11 
mRNA expression. AQP11 was expressed to a greater (p < 0.05) extent in the subcutaneous adipose 
tissue (Figure 1c). However, obesity and obesity-associated T2D were associated with increased (p < 
0.05) AQP11 mRNA and protein levels in omental adipose tissue (Figure 1d,f), without changes in 
subcutaneous fat (Figure 1e,g). AQP11 protein expression levels in visceral fat were positively 
correlated with markers of adiposity, such as BMI (r = 0.48, p = 0.004), body fat (r = 0.49, p = 0.004), 
and leptin (r = 0.42, p = 0.016), and with the acute-phase reactant CRP (r = 0.37, p = 0.041), suggesting 
an involvement of this superaquaporin in obesity-associated inflammation. 
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Figure 1. Impact of obesity and obesity-associated T2D on AQP11 expression in paired omental and 
subcutaneous adipose tissue samples. (a) Immunohistochemical detection of AQP11 in omental (left 
panels) and subcutaneous (right panels) fat depots obtained from patients with obesity 
(magnification, ×200; scale bar = 50 µm). Comparison of mRNA levels of AQP11 in freshly isolated 
adipocytes and SVFC from omental WAT from patients with obesity classified according to their 
degree of insulin resistance (b) as well as in human omental and subcutaneous white adipose tissue 
(WAT) (c). Bar graphs show the expression of AQP11 mRNA and protein in omental (d and f) and 
subcutaneous (e and g) WAT obtained from lean individuals, obese patients with normoglycemia 
(NG), impaired glucose tolerance (IGT), or type 2 diabetes (T2D). Representative blots are shown at 
the bottom of the histograms. * p < 0.05, ** p < 0.01 vs mRNA expression in omental WAT or in lean 
subjects. a p < 0.05 vs mRNA expression in the adipocyte fraction. 
3.2. AQP11 is Increased During Adipocyte Differentiation and Lipolysis 
To gain further insight into the role of AQP11 in the onset of obesity, we evaluated the expression 
and subcellular location of this superaquaporin during adipocyte differentiation and lipolysis. In line 
with the above-mentioned results, AQP11 transcription was increased during late adipocyte 
differentiation (Figure 2a), confirming that mature adipocytes are the major source of AQP11 in 
human adipose tissue. Under basal conditions, AQP11-positive immunosignal was observed as 
puncta around and between lipid droplets (Figure 2d). Subcellular fractionation studies of 
differentiated adipocytes revealed that AQP11 mostly associated with ER-enriched cellular 
membranes, as indicated by the presence of the ER marker calnexin (Figure 2b) and not in fractions 
containing lipid droplets (immunolabeled for perilipin) or cytosol (immunolabeled for β-actin). Upon 
24 h stimulation with isoproterenol, AQP11 mRNA was increased (p < 0.05) (Figure 2c), and protein 
tended to appear more concentrated around the lipid droplets (Figure 2d). 
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Figure 2. Characterization of AQP11 during adipocyte differentiation and lipolysis. (a) Time course 
of AQP11 mRNA expression during adipocyte differentiation. (b) AQP11 protein expression in 
differentiated adipocyte fractions corresponding to lipid droplets (LD), cytosol (C) or membranes (M); 
perilipin, β-actin, and calnexin were used as markers for lipid droplets, cytoplasm, or endoplasmic 
reticulum membrane, respectively. AQP11 mRNA expression (c) and protein redistribution (d) after 
24 h treatment with isoproterenol (10 µmol/L) in human differentiated adipocytes. Gene expression 
in SVFC in day 0 or control adipocytes were assumed to be 1. * p < 0.05 vs mRNA expression in 
omental WAT; * p < 0.05 vs mRNA expression in SVFC in day 0 or control adipocytes. 
3.3. AQP11 Participates in TGF-β1-induced Endoplasmic Reticulum Stress 
AQP11 also acts as a peroxiporin for the efflux of cellular H2O2 and alleviation of ER stress [10]. 
Since TNF-α and TGF-β1 are major inductors of inflammation and ER stress in the adipose tissue, we 
next analyzed their impact on AQP11 expression and subcellular distribution in adipocytes. Confocal 
microscopy studies revealed lower immunostaining of AQP11 in adipocytes stimulated with TNF-α 
(10 ng/mL) or TGF-β1 (10 ng/mL) for 24 h (Figure 3a), with the distribution of this superaquaporin 
appearing more prominently surrounding the lipid droplets. Adipocytes treated with different 
concentrations of TNF-α exhibited lower mRNA (p = 0.074) and protein (p = 0.144) expression of 
AQP11, but differences fell out of statistical significance (Figure 3b,d). Increasing concentrations of 
TGF-β1 significantly diminished the transcript (p = 0.035) and protein (p = 0.004) levels of AQP11 in 
adipocytes (Figure 3c,d). 
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Figure 3. Proinflammatory factors TNF-α and TGF-β1 induce changes in AQP11 expression and 
subcellular distribution. (a) Immunocytochemical detection of AQP11 in differentiated adipocytes 
(day 10) under basal conditions (left panel) and after the stimulation for 24 h with TNF-α (10 ng/mL) 
(middle panel) or TGF-β1 (10 ng/mL) (right panel). Bar graphs show AQP11 mRNA (b and c) and 
protein (d and e) after 24 h treatment with different concentrations of TNF-α and TGF-β1 in 
differentiated omental adipocytes. Representative blots are shown at the bottom of the histograms. * 
p <0.05, ** p < 0.01 vs unstimulated cells. 
Since TGF-β1 appears to be a major regulator of AQP11 in adipocytes, we focused the next 
experiments on this proinflammatory factor. Given their relevance in the context of obesity, we next 
analyzed the expression of the genes encoding ER stress markers ATF4 and C/EBP homologous 
protein (CHOP) (ATF4 and DDIT3) [20,28]. As expected, TGF-β1 induced an increased (p < 0.05) the 
expression of these ER stress markers at the concentrations of 1 and 10 ng/mL (Figure 4a,b). To 
evaluate whether AQP11 is necessary for TGF-β1-induced ER stress, we downregulated the 
constitutive expression levels of AQP11 in human omental adipocytes using a pool of siRNAs 
targeting AQP11 mRNA, getting an average knockdown of 92% (Figure S2). AQP11 gene silencing 
upregulated (p < 0.05) in ATF4 and DDIT3 mRNA levels under basal conditions, and further 
aggravated (p < 0.05) TGF-β1-induced activation of both ER stress markers (Figure 4c,d). 
 
Figure 4. Impact of AQP11 gene silencing on basal and TGF-β1-induced ER stress. Bar graphs show 
ATF4 and DDIT3 transcript levels in omental adipocytes after 24 h treatment with different 
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concentrations of TGF-β1 (a and b) as well as in AQP11-silenced adipocytes after stimulation with 
TGF-β1 10 ng/mL for 24 h (c and d). * p < 0.05, ** p < 0.01 vs unstimulated cells; ap < 0.05 effect of TGF-
β1 treatment; bp < 0.05 effect of AQP11 gene silencing. 
4. Discussion 
AQP11 is expressed mainly in mature adipocytes of omental and subcutaneous adipose tissue. 
Our results showed an increase in AQP11 expression during adipocyte differentiation, a process 
accompanied by lipid droplet (LD) biogenesis. In adipocytes, nascent LDs arise from the bilayer 
membrane of the ER [29]. A previous study revealed that AQP11 partially colocalizes with perilipin-
1 [9], a constitutive LD-coating protein that seems to move between LDs and ER [30,31]. Accordingly, 
our data confirmed that AQP11 is located in the ER membrane at the vicinity of LDs, suggesting its 
potential contribution to glycerol uptake for triacylglycerol synthesis within the ER-emerging LDs 
(Figure 5a). The functionality of AQP11 as a glycerol channel was evidenced by its responsiveness to 
isoproterenol-induced lipolysis, a catabolic process leading to triacylglycerol breakdown into 
glycerol and FFA [32]. The β-adrenergic agonist isoproterenol stimulates glycerol efflux from 
adipocytes triggering the translocation of aquaglyceroporins from the cytosolic fraction (AQP3) or 
lipid droplets (AQP7 and AQP10) to the plasma membrane [24,33–35]. Notably, our confocal 
microscopy studies revealed that isoproterenol reinforced the presence of AQP11 around LDs, 
instead of promoting its trafficking towards the plasma membrane, like aquaglyceroporins do. In this 
sense, lipolysis induces LD shrinkage and fragmentation into microLDs during triacylglycerol 
breakdown [36]. Thus, the marked presence of AQP11 around LDs after isoproterenol-induced 
lipolysis might reflect an efficient glycerol mobilization during microLD formation in the ER under 
physiological conditions (Figure 5). 
 
Figure 5. (a) Under physiological conditions, AQP11 contributes to glycerol mobilization for 
triacylglycerol synthesis in nascent lipid droplets in the ER. (b) In obesity, the peroxiporin activity of 
AQP11 appears to contribute to the alleviation of ER stress induced by the increased ROS production 
due to mitochondrial dysfunction under lipotoxic and inflammatory conditions. Although 
proinflammatory factors, such as TNF-α, TGF-β1, or LPS downregulate AQP11, this superaquaporin 
is upregulated in obesity, suggesting that other factors are involved in AQP11 regulation in human 
adipocytes. ATGL, adipocyte triglyceride lipase; HSL, hormone-sensitive lipase. 
In obesity, catecholamine-induced lipolysis is markedly increased in visceral fat due to increased 
activity of lipolytic β-adrenergic receptors and decreased activity of anti-lipolytic α2-adrenoceptors 
[32]. Accordingly, circulating levels of glycerol and FFA were observed in both obese groups of our 
cohort. Interestingly, the sustained elevation of FFA in the obese state has the potential to increase 
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reactive oxygen species (ROS) production and ER stress in adipocytes [21]. In this regard, ROS 
oxidizes nascent proteins and increases misfolded and unfolded proteins in the ER. Although all 
organelles and cell compartments produce ROS, mitochondrial generation of H2O2 is generally 
considered to be the major source of oxidants. ROS, and particularly H2O2, overwhelm the ER 
structure and chaperone activity, initiating a vicious circle of stress, mitochondrial dysfunction, and 
ER stress worsening [20–22]. The ER and mitochondria join at multiple contact sites to form specific 
domains, termed mitochondria-ER associated membranes (MAMs), which prompt danger signal 
sensing and inflammatory responses. Interestingly, AQP11 accumulates partly in MAMs in HeLa 
cells [10]. Thus, it seems plausible that the herein observed upregulation of AQP11 mRNA and 
protein levels in visceral fat might constitute a compensatory mechanism to protect adipocytes 
against ER stress induced by lipotoxicity in obesity (Figure 5). Further investigations analyzing the 
role of AQP11 in ER-mitochondria contact sites (MAMs) to sense the level of danger and to coordinate 
the appropriate inflammatory response in visceral adipocytes are warranted. 
Growing evidence supports that obesity-associated inflammation and ER stress take also place 
in the subcutaneous fat depot [37]. In the context of obesity-associated insulin resistance, 
subcutaneous adipose tissue can be as deleterious as visceral fat, exhibiting increased markers of 
inflammation, oxidative, and ER stress [25]. Accordingly, our data showed that transcript and protein 
levels of AQP11 were higher in the subcutaneous adipose tissue of obese patients with type 2 diabetes 
than those found in individuals with normoglycemia. However, no significant differences were 
found, which might be ascribed to the short diabetes history (<2–3 years or even de novo diagnosis) 
of our cohort. Future studies in patients with obesity and a longer type 2 diabetes history are 
warranted to address this point. 
Chronic UPR activation in adipocytes is directly linked to the activation of inflammatory 
signaling pathways that regulate the transcription of proinflammatory cytokines, including TNF-α 
and TGF-β1 [38]. Moreover, the simultaneous activation of inflammation and mitochondrial 
dysfunction trigger ROS production, perpetuating ER stress in the context of obesity [38,39]. In the 
present study, inflammatory factors TNF-α, and especially TGF-β1, decreased AQP11 mRNA and 
protein in human visceral adipocytes. TNF-α has been also reported to decrease the protein 
expression of another aquaglyceroporin, AQP9, in a hepatocyte model of fatty liver disease [40]. 
IKK/NF-κB participates in the proinflammatory signal transduction induced by ER stress during 
adipocyte dysfunction [41]. In line with this observation, Chiadak and colleagues [42] found that the 
exogenous inflammatory factor LPS downregulates Aqp11 mRNA levels in 3T3-L1 adipocytes 
through TLR4-induced activation of JNK and NF-κB pathways. Thus, alterations in the IKK/NF-κB 
signal might also be involved in ER stress during AQP11 silencing. Importantly, AQP11 gene 
silencing induced an increased basal and TGF-β1 expression of ER stress markers, ATF4 and CHOP, 
supporting the crucial role of AQP11 in ER homeostasis in human visceral adipocytes. Together, it 
seems plausible that, in obesity, the overexpression of AQP11 also alleviates inflammation-induced 
ER stress in visceral adipocytes due to its peroxiporin activity (Figure 5b). 
5. Conclusions 
In summary, our data sheds light into novel functions of AQP11 due to its ability to transport 
glycerol and H2O2 through the ER membrane in human adipose tissue (Figure 5). Under physiological 
conditions, AQP11 is an ER-resident protein that allows glycerol mobilization for the synthesis of 
triacylglycerols in nascent lipid droplets in the basal state or after β-adrenergic lipolytic stimulation. 
However, in the obese state, its overexpression in the visceral adipose tissue appears to be a 
compensatory mechanism to alleviate ER stress due to its ability to transport H2O2. In this regard, the 
downregulation of AQP11 in visceral adipocytes aggravates TGF-β1-induced ER stress, as evidenced 
by the increased ER markers ATF4 and CHOP. Targeting AQP11 to reduce ER stress might constitute 
a potential therapeutic target for the treatment of obesity. 
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